Intellia Therapeutics
NTLA
NTLA
65 hedge funds and large institutions have $242M invested in Intellia Therapeutics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
20% less capital invested
Capital invested by funds: $302M → $242M (-$59.1M)
Holders
65
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.29M | |
| 2 | +$1.78M | |
| 3 | +$1.13M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$596K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$532K |
Top Sellers
| 1 | -$1.87M | |
| 2 | -$1.3M | |
| 3 | -$767K | |
| 4 |
GL
GLG LLC
New York
|
-$730K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$582K |